TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | 1 | -3 | 0 | 0 | 0 | -1 |
| S | %wins | 100 | 0 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/15/25 16:57 | 8/13/25 | XERS | Xeris Biopharma Holdings, Inc. | Health | Drug | Pharmaceutical Preparations | Johnson John | IL | D | S | -786 | 7.32 | 0 | -108 | -11 | 833 | D | ||||||||||||||||
6/11/25 16:23 | 6/9/25 | AXGN | Axogen, Inc. | MN | Health | ElcMd | Electromedical & Electrothera | Johnson John | FL | D | S | -43 | 10.61 | 0 | -4 | -14 | 25 | D | |||||||||||||||
7/2/19 21:09 | 6/27/19 | MLNT | Melinta Therapeutics, Inc. /new/ | DE | Health | Drug | Pharmaceutical Preparations | Johnson John | NJ | DO | CEO | S | -72 | 5.57 | 0 | -13 | -26 | 37 | D | ||||||||||||||
1/4/12 16:17 | 1/3/12 | SVNT | Savient Pharmaceuticals Inc | DE | Health | MdCm | Medicinal Chemicals & Botanic | Johnson John | NJ | DO | CEO | S | -41 | 2.30 | 4 | -18 | -7 | 252 | D | -84 | -80 | -69 | -38 | -2 | 6 | 3 | 8 | 0 | 1 | -3 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |